** Medical device maker Cooper Companies' COO.O shares jump 13% to $87 premarket
** Co says it is initiating a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value
** Co says it is actively focused on improving performance in core markets, expanding market share, enhancing operational efficiency and generating strong returns through capital deployment initiatives as part of the review
** Co forecasts fiscal 2026 revenue of $4.299 bln to $4.338 bln vs analysts' estimate of $4.32 bln
** "It's encouraging to see organic growth guidance starting at a level that gives the company more room to maneuver, and adding total shareholder return to the executive performance rubric is also a solid step in the right direction for the strategic review" - J.P.Morgan
** 11 of 20 brokerages rate the stock "buy" or higher, eight "hold" and one "sell" or lower; their median PT is $85.5, as per data compiled by LSEG
** YTD, stock fell 16.2% through Thursday
(Reporting by Joel Jose in Bengaluru)
((mailto: joeljose@thomsonreuters.com))
Comments